Saxagliptin, sold under the brand name Onglyza, is an oral hypoglycemic of the dipeptidyl peptidase-4 inhibitor class. Early development was solely by Bristol-Myers Squibb; in 2007 AstraZeneca joined with Bristol-Myers Squibb to co-develop the final compound and collaborate on the marketing of the drug.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Saxagliptin industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Purity?98%
Purity?99%
Market Segment by Product Application
Saxagliptin Tablets
Other
Finally, the report provides detailed profile and data information analysis of leading company.
AstraZeneca
Tapi Teva
API Polpharma
Metrochem API
Tianjin Scipharmacn
Taizhou Canova Bio-technology
Minxiang Pharma
Huaman Xincaiiao Keji
Jinan Lead Pharm-Chemical
Hebei Kangtai Pharma
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Saxagliptin consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Saxagliptin market by identifying its various subsegments.
3.Focuses on the key global Saxagliptin manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Saxagliptin with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Saxagliptin submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Saxagliptin Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Saxagliptin Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Saxagliptin Segment by Type
2.1.1 Purity?98%
2.1.2 Purity?99%
2.2 Market Analysis by Application
2.2.1 Saxagliptin Tablets
2.2.2 Other
2.3 Global Saxagliptin Market Comparison by Regions (2017-2027)
2.3.1 Global Saxagliptin Market Size (2017-2027)
2.3.2 North America Saxagliptin Status and Prospect (2017-2027)
2.3.3 Europe Saxagliptin Status and Prospect (2017-2027)
2.3.4 China Saxagliptin Status and Prospect (2017-2027)
2.3.5 Japan Saxagliptin Status and Prospect (2017-2027)
2.3.6 Southeast Asia Saxagliptin Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Saxagliptin Industry Impact
2.5.1 Saxagliptin Business Impact Assessment - Covid-19
2.5.2 Market Trends and Saxagliptin Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Saxagliptin Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Saxagliptin Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Saxagliptin Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Saxagliptin Manufacturer Market Share
3.5 Top 10 Saxagliptin Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Saxagliptin Market
3.7 Key Manufacturers Saxagliptin Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Saxagliptin Industry Key Manufacturers
4.1 AstraZeneca
4.1.1 Compan Detail
4.1.2 AstraZeneca Saxagliptin Product Introduction, Application and Specification
4.1.3 AstraZeneca 130 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 AstraZeneca News
4.2 Tapi Teva
4.2.1 Compan Detail
4.2.2 Tapi Teva Saxagliptin Product Introduction, Application and Specification
4.2.3 Tapi Teva Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 AstraZeneca News
4.3 API Polpharma
4.3.1 Compan Detail
4.3.2 API Polpharma Saxagliptin Product Introduction, Application and Specification
4.3.3 API Polpharma Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 API Polpharma News
4.4 Metrochem API
4.4.1 Compan Detail
4.4.2 Metrochem API Saxagliptin Product Introduction, Application and Specification
4.4.3 Metrochem API Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Metrochem API News
4.5 Tianjin Scipharmacn
4.5.1 Compan Detail
4.5.2 Metrochem API Saxagliptin Product Introduction, Application and Specification
4.5.3 Tianjin Scipharmacn Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Tianjin Scipharmacn News
4.6 Taizhou Canova Bio-technology
4.6.1 Compan Detail
4.6.2 Taizhou Canova Bio-technology Saxagliptin Product Introduction, Application and Specification
4.6.3 Taizhou Canova Bio-technology Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Taizhou Canova Bio-technology News
4.7 Minxiang Pharma
4.7.1 Compan Detail
4.7.2 Minxiang Pharma Saxagliptin Product Introduction, Application and Specification
4.7.3 Minxiang Pharma Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Huaman Xincaiiao Keji
4.8.1 Compan Detail
4.8.2 Huaman Xincaiiao Keji Saxagliptin Product Introduction, Application and Specification
4.8.3 Huaman Xincaiiao Keji Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Huaman Xincaiiao Keji News
4.9 Jinan Lead Pharm-Chemical
4.9.1 Compan Detail
4.9.2 Jinan Lead Pharm-Chemical Saxagliptin Product Introduction, Application and Specification
4.9.3 Jinan Lead Pharm-Chemical Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Jinan Lead Pharm-Chemical News
4.10 Hebei Kangtai Pharma
4.10.1 Compan Detail
4.10.2 Hebei Kangtai Pharma Saxagliptin Product Introduction, Application and Specification
4.10.3 Hebei Kangtai Pharma Saxagliptin Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Hebei Kangtai Pharma News
5 Global Saxagliptin Market Segment by Big Type
5.1 Global Saxagliptin Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Saxagliptin Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Saxagliptin Revenue and Market Share by Big Type (2017-2022)
5.2 Purity?98% Sales Growth Rate and Price
5.2.1 Global Purity?98% Sales Growth Rate (2017-2022)
5.2.2 Global Purity?98% Price (2017-2022)
5.3 Purity?99% Sales Growth Rate and Price
5.3.1 Global Purity?99% Sales Growth Rate (2017-2022)
5.3.2 Global Purity?99% Price (2017-2022)
6 Global Saxagliptin Market Segment by Big Application
6.1 Global Saxagliptin Sales Market Share by Big Application (2017-2022)
6.2 Saxagliptin Tablets Sales Growth Rate (2017-2022)
6.3 Other Sales Growth Rate (2017-2022)
7 Global Saxagliptin Forecast
7.1 Global Saxagliptin Revenue, Sales and Growth Rate (2022-2027)
7.2 Saxagliptin Market Forecast by Regions (2022-2027)
7.2.1 North America Saxagliptin Market Forecast (2022-2027)
7.2.2 Europe Saxagliptin Market Forecast (2022-2027)
7.2.3 China Saxagliptin Market Forecast (2022-2027)
7.2.4 Japan Saxagliptin Market Forecast (2022-2027)
7.2.5 Southeast Asia Saxagliptin Market Forecast (2022-2027)
7.2.6 Other Regions Saxagliptin Market Forecast (2022-2027)
7.3 Saxagliptin Market Forecast by Type (2022-2027)
7.3.1 Global Saxagliptin Sales Forecast by Type (2022-2027)
7.3.2 Global Saxagliptin Market Share Forecast by Type (2022-2027)
7.4 Saxagliptin Market Forecast by Application (2022-2027)
7.4.1 Global Saxagliptin Sales Forecast by Application (2022-2027)
7.4.2 Global Saxagliptin Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Saxagliptin Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Saxagliptin Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Saxagliptin
Figure Market Concentration Ratio and Market Maturity Analysis of Saxagliptin
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Saxagliptin Market Size by Big Type
Figure Global Market Share of Saxagliptin by Big Type in 2021
Figure Purity?98% Picture (2017-2022)
Global Saxagliptin Market Size by Big Application
Table Global Saxagliptin Market Size by Application
Figure Global Saxagliptin Market Share by Big Application in 2021
Figure Saxagliptin Tablets Picture
Figure Other Picture
Table Global Saxagliptin Comparison by Regions (M USD) (2017-2027)
Figure Global Saxagliptin Market Size (Million US$) (2017-2027)
Figure North America Saxagliptin Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Saxagliptin Revenue (Million US$) Growth Rate (2017-2027)
Figure China Saxagliptin Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Saxagliptin Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Saxagliptin Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Saxagliptin Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Saxagliptin Sales by Manufacturer (2017-2022)
Figure Global Saxagliptin Sales Market Share by Manufacturer in 2021
Table Global Saxagliptin Revenue by Manufacturer (2017-2022)
Figure Global Saxagliptin Revenue Market Share by Manufacturer in 2021
Table Global Saxagliptin Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Saxagliptin Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Saxagliptin Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Saxagliptin Market
Table Key Manufacturers Saxagliptin Product Type
Table Mergers & Acquisitions Planning
Table AstraZeneca Company Profile
Table Saxagliptin Product Introduction, Application and Specification of AstraZeneca
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Tapi Teva Company Profile
Table Saxagliptin Product Introduction, Application and Specification of Tapi Teva
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Tapi Teva Recent Development
Table API Polpharma Company Profile
Table Saxagliptin Product Introduction, Application and Specification of API Polpharma
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table API Polpharma Main Business
Table API Polpharma Recent Development
Table Metrochem API Company Profile
Table Saxagliptin Product Introduction, Application and Specification of Metrochem API
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Metrochem API Main Business
Table Metrochem API Recent Development
Table Metrochem API Main Business
Table Metrochem API Recent Development
Table Tianjin Scipharmacn Company Profile
Table Saxagliptin Product Introduction, Application and Specification of Tianjin Scipharmacn
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Tianjin Scipharmacn Main Business
Table Tianjin Scipharmacn Recent Development
Table Taizhou Canova Bio-technology Company Profile
Table Saxagliptin Product Introduction, Application and Specification of Taizhou Canova Bio-technology
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Taizhou Canova Bio-technology Main Business
Table Taizhou Canova Bio-technology Recent Development
Table Minxiang Pharma Company Profile
Table Saxagliptin Product Introduction, Application and Specification of Minxiang Pharma
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Minxiang Pharma Main Business
Table Minxiang Pharma Recent Development
Table Huaman Xincaiiao Keji Company Profile
Table Saxagliptin Product Introduction, Application and Specification of Huaman Xincaiiao Keji
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Huaman Xincaiiao Keji Main Business
Table Huaman Xincaiiao Keji Recent Development
Table Jinan Lead Pharm-Chemical Company Profile
Table Saxagliptin Product Introduction, Application and Specification of Jinan Lead Pharm-Chemical
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Jinan Lead Pharm-Chemical Main Business
Table Jinan Lead Pharm-Chemical Recent Development
Table Hebei Kangtai Pharma Company Profile
Table Saxagliptin Product Introduction, Application and Specification of Hebei Kangtai Pharma
Table Saxagliptin Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hebei Kangtai Pharma Main Business
Table Hebei Kangtai Pharma Recent Development
Figure Global Saxagliptin Sales and Growth Rate (2017-2022)
Figure Global Saxagliptin Revenue and Growth Rate (2017-2022)
Table Global Saxagliptin Sales by Regions (2017-2022)
Figure Global Saxagliptin Sales Market Share by Regions in 2021
Table Global Saxagliptin Revenue by Regions (2017-2022)
Figure Global Saxagliptin Revenue Market Share by Regions in 2021
Figure North America Saxagliptin Sales and Growth Rate (2017-2022)
Figure Europe Saxagliptin Sales and Growth Rate (2017-2022)
Figure China Saxagliptin Sales and Growth Rate (2017-2022)
Figure Japan Saxagliptin Sales and Growth Rate (2017-2022)
Figure Southeast Asia Saxagliptin Sales and Growth Rate (2017-2022)
Figure Other Regions Saxagliptin Sales and Growth Rate (2017-2022)
Table Global Saxagliptin Sales by Big Type (2017-2022)
Table Global Saxagliptin Sales Market Share by Big Type (2017-2022)
Figure Global Saxagliptin Sales Market Share by Big Type in 2019
Table Global Saxagliptin Revenue by Big Type (2017-2022)
Table Global Saxagliptin Revenue Market Share by Big Type (2017-2022)
Table Global Saxagliptin Revenue Market Share by Big Type in 2019
Figure Global Purity?98% Sales Growth Rate (2017-2022)
Figure Global Purity?98% Price (2017-2022)
Figure Global Purity?99% Sales Growth Rate (2017-2022)
Table Global Saxagliptin Sales by Big Application (2017-2022)
Table Global Saxagliptin Sales Market Share by Big Application (2017-2022)
Figure Global Saxagliptin Sales Market Share by Big Application in 2019
Figure Global Saxagliptin Tablets Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Saxagliptin Sales and Growth Rate (2022-2027)
Figure Global Saxagliptin Revenue and Growth Rate (2022-2027)
Table Global Saxagliptin Sales Forecast by Regions (2022-2027)
Table Global Saxagliptin Market Share Forecast by Regions (2022-2027)
Figure North America Sales Saxagliptin Market Forecast (2022-2027)
Figure Europe Sales Saxagliptin Market Forecast (2022-2027)
Figure China Sales Saxagliptin Market Forecast (2022-2027)
Figure Japan Sales Saxagliptin Market Forecast (2022-2027)
Figure Southeast Asia Sales Saxagliptin Market Forecast (2022-2027)
Figure Other Regions Sales Saxagliptin Market Forecast (2022-2027)
Table Global Saxagliptin Sales Forecast by Type (2022-2027)
Table Global Saxagliptin Market Share Forecast by Type (2022-2027)
Table Global Saxagliptin Sales Forecast by Application (2022-2027)
Table Global Saxagliptin Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Saxagliptin
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Saxagliptin Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Saxagliptin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Saxagliptin Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Saxagliptin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Saxagliptin Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Saxagliptin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Saxagliptin Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Saxagliptin Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Global Graphitized Carbon Black (GCB) Ma..
Graphitized carbon black is a black particle that can be use..
+16467917070US (Toll Free)